Way to get all doom and gloom Oldcat. It's just the initial data of one trial which is a little late. In the company preso in oct last year it said the initial data for the lupus trial was anticipated to be available in 4Q 2013. The smoking cessation trial initial results r delayed too but we had an announcement explaining that. For a market cap under 40mil and 3 phase II's underway, there's potential for massive gains this year IMO.
Btw regarding cash position, the $500,000 for the in-licensing agreement is being paid in monthly installments, which will help us scrape through for a bit longer without needing to raise cash IMO. Hopefully results being released before then anyway. The quarterly will tell
IVX Price at posting:
7.8¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)